Skip to main content

Table 3 Univariate analysis for prognostic factors of bone survival

From: Resistance training concomitant to radiotherapy of spinal bone metastases – survival and prognostic factors of a randomized trial

 

Intervention group (n = 30)

Control group (n = 30)

 

HR

CI 95 %

P-value

HR

CI 95 %

P-value

Pathological fracture

1.288

0.371–4.467

0.690

0.833

0.343–2.020

0.686

KPS

0.527

0.216–1.289

0.161

0.872

0.372–2.043

0.752

Localization

0.588

0.209–1.655

0.315

1.166

0.504–2.694

0.720

Number of metastases

0.602

0.200–1.812

0.366

1.052

0.469–2.360

0.902

Breast cancer

0.230

0.028–1.923

0.175

0.103

0.024–0.442

0.002

NSCLC

2.442

0.834–7.145

0.103

0.968

0.346–2.712

0.951

Prostate cancer

0.950

0.237–3.804

0.942

0.160

0.050–0.511

0.002

Cerebral metastases

1.529

0.409–5.716

0.528

3.211

1.063 − 9.695

0.038